Zivo Bioscience annual free cash flow
2010
2011
2012
2013
Zivo Bioscience reported −$3.0M in free cash flow for fiscal 2013, a decrease of $1.2M from the previous fiscal year.
View full Zivo Bioscience company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2013 | 2013-12-31 | −$3.0M | −$1.2M | — | — |
| 2012 | 2012-12-31 | −$1.8M | −$477,916 | — | — |
| 2011 | 2011-12-31 | −$1.3M | $170,508 | — | −1250.20% |
| 2010 | 2010-12-31 | −$1.5M | — | — | −1776.19% |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2013 | 2013-09-30 | −$783,470 | −$249,261 | — | — |
| Q4 2012 | 2012-12-31 | −$356,687 | $167,000 | — | — |
| Q3 2012 | 2012-09-30 | −$468,575 | −$214,139 | — | — |
| Q2 2012 | 2012-06-30 | −$417,293 | −$221,079 | — | — |
| Q1 2012 | 2012-03-31 | −$534,209 | −$209,696 | — | — |
| Q4 2011 | 2011-12-31 | −$523,687 | −$215,959 | — | −12917.78% |
| Q3 2011 | 2011-09-30 | −$254,436 | — | — | −713.75% |
| Q2 2011 | 2011-06-30 | −$196,214 | — | — | −704.29% |
| Q1 2011 | 2011-03-31 | −$324,513 | — | — | −893.26% |
| Q3 2010 | 2010-09-30 | −$307,728 | — | — | −1595.19% |
Zivo Bioscience's latest reported quarter, Q3 2013, generated −$783,470 in free cash flow, a decrease of $249,261 year over year.
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Zivo Bioscience filings at SEC.gov ↗